More information: Mohamed Adil et al, Preeclampsia risk prediction from prenatal cell-free DNA screening, Nature Medicine (2025). DOI: 10.1038/s41591-025-03509-w Provided by University of ...

The global Cell-free fetal DNA testing market is estimated to be valued at USD 1,687.8 million in 2025 and is projected to reach USD 3,051.5 million by 2035, registering a compound annual growth rate ...

Cell-free fetal DNA testing: Some of your baby’s DNA winds up in your blood. After 10 weeks, your doctor takes a sample from you, and a lab tests the baby’s DNA in it for signs of: Down syndrome ...

The global Cell-Free DNA (cfDNA) Testing Market is forecasted to be worth USD 22.41 Billion by 2027, according to a new report by Emergen Research. The global Cell-Free DNA (cfDNA) testing market ...

Cell-free DNA analyses were accurate in detecting fetal antigen status as early as 10 weeks’ gestation in women with alloimmunized pregnancies, according to results of a large, diverse U.S ...

NIPT works by testing all the cell-free DNA circulating in the mother's blood. Most of the DNA comes from the mother. Only 10% to 20% of it comes from the baby.

Cell-Free Fetal DNA Testing MarketThe global cell-free fetal DNA testing market is experiencing robust growth, with revenue projected to climb from USD 1,566.0 million in 2024 to USD 3,051.5 million ...

For the new cell-free DNA testing, a small amount of a person's blood is tested for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in theory ...

Cell-free DNA testing uses a small amount of a person's blood and tests it for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in theory ...

A new blood test utilizing cell-free DNA from the placenta can predict preterm preeclampsia with 80% accuracy. This condition, causing significant maternal and fetal mortality, has been difficult ...